Peptide Highlights

by EPS Pool of Writers


Peptide Therapeutics for COVID-19

Posted on Sep 18th, 2020

As the world struggles to cope with the current COVID-19 pandemic, in this edition of “Peptide Highlights” we present a survey of peptide drugs which are being investigated as potential therapies for the disease. For more please download PDF file. Contributed by Susan J. Tzotzos Susan…

Continue reading >

Imine-derived macrocyclic peptides

Posted on Jul 19th, 2020

In recent years, macrocyclic peptides are attracting a growing attention of pharmaceutical/biotech companies and academic groups. Their intermediate size, in-between small-molecule drugs and biotherapeutics, enable their utility as modulators of therapeutically relevant protein-protein interactions…

Continue reading >

Life imitates cookery: lysinoalanine crosslinks in peptides and proteins

Posted on Jun 5th, 2020

The lysinoalanine crosslink – a type of protein post-translational modification – was initially discovered in vitro and later found to occur in cooked and processed food. Curiously, the same kind of crosslink occurs in certain peptide antibiotics; and there is evidence to suggest that it also…

Continue reading >

The hitchhiker´s guide to chemoselectivity in chemical protein synthesis

Posted on Mar 10th, 2020

Posttranslational modifications (PTMs) allow proteins to perform a variety of physiological functions. Thus, it is of prime importance to elucidate their role on proteins in physiological and/or pathophysiological processes. However, molecular biological methods to generate proteins either does not…

Continue reading >

Peptide Drugs of the Decade

Posted on Dec 30th, 2019

The approaching end of another decade prompted this short review of peptide drugs that successfully reached the European market from 2010 to the present. The article also gives a comparison of numbers of marketing authorisations granted to peptide drugs in Europe and the US over the last two…

Continue reading >

“Sweet” Peptides

Posted on Nov 25th, 2019

Naturally occurring glycopeptides (GPs, peptide + sugar) and glycoproteins are crucial players in many biological processes. N- and O-glycosylation is in fact one of the most important post-translational modifications in vivo. Glycoproteins are fundamental in cell-cell communications, recognition…

Continue reading >

The Other Sanger Sequencing

Posted on Sep 27th, 2019

Inspired by a recent celebration of the work of Martin and Synge, this article examines the role of chromatography in efforts to elucidate the primary structures of proteins. It touches on, as I have referred to it, ‘the other Sanger sequencing’ – the method by which the first protein…

Continue reading >

Why protein chemist chose phosphorus for protein bioconjugation?

Posted on Jul 10th, 2019

In the last two decades, phosphorus-mediated chemoselective ligation reactions acquired the “gold” status for in vivo labeling of biomolecules. However, some drawbacks of phosphines, such as directing non-canonical amino acids (e.g. azides) as their reaction partners limits the scope of these…

Continue reading >

Conjugates of Vancomycin and Cell-penetrating Peptides – New Weapons in the Armoury against Drug Resistant Bacteria

Posted on Jun 9th, 2019

Staying one step ahead in the arms race against antibiotic resistant pathogenic bacteria is an ongoing challenge to the ingenuity of medicinal chemists. Multidrug-resistance has become a menacing threat to the antibiotic armoury used by clinicians to treat nosocomial and community-acquired…

Continue reading >

Bioactive peptides from food protein degradation: Legume peptides

Posted on Apr 4th, 2019

Animal and plant proteins, upon in vitro or in vivo digestion, have not only a nutritional role but are a rich source of bioactive peptides initially encrypted in the native protein sequences. The activities of these peptides range from antioxidant, antihypertensive or anti-obesity to antimicrobial…

Continue reading >

Nature’s Shotgun Proteomics

Posted on Feb 26th, 2019

The mammalian immune system, as part of its response to a viral infection, does something akin to a shotgun proteomics experiment. Viral proteins are digested, and the resulting peptides are presented—as a mixture—in a form that can be recognised by circulating T cells. In this article, I…

Continue reading >

Thanatin – an Insect-derived Antimicrobial Peptide Active against Pathogenic Gram-negative Bacteria

Posted on Jan 3rd, 2019

Swiss researchers have recently revealed the mechanism by which the insect-derived antimicrobial peptide thanatin targets the intermembrane protein complex required for lipopolysaccharide (LPS) transport in Escherichia coli. Employing a series of elegant techniques directed at increasing levels of…

Continue reading >

Peptide vaccines: the future of immunotherapy?

Posted on Dec 8th, 2018

It is widely accepted that vaccines are valuable preparations for prevention against life-threatening diseases such as polio, measles and smallpox and their utilization led to control and/or eradication of aforementioned infectious diseases. Common drawbacks in classical vaccine formulations led to…

Continue reading >

Targeted protein degradation as a new paradigm in drug discovery. Is there a role for peptides?

Posted on Oct 24th, 2018

Despite the large number of new, therapeutically relevant proteins discovered in recent years, classical drug discovery strategies have not been particularly successful in finding suitable small-molecule modulators. Targeted protein degradation has raised considerable interest from…

Continue reading >

Small Proteins, Big Data

Posted on Sep 5th, 2018

The possibility that a subset of biological molecules has been overlooked, and is waiting to be discovered, is always intriguing. For small proteins (proteins of around 100 amino acid residues or fewer) there is evidence to suggest that this is indeed the case. In this article, I examine the…

Continue reading >

Inhibition of Amyloidogenesis by Synthetic Enantiomeric Peptides

Posted on Aug 4th, 2018

A synthetic peptide composed of alternating L- and D-amino acid residues has been recently shown to inhibit aggregation and reduce toxic effects in neuroblastoma cells, of the beta-amyloid peptide, Aβ, implicated in Alzheimer’s disease. In contrast, a “twin” peptide with the same sequence,…

Continue reading >

New enzymatic approaches for the generation of peptide and protein conjugates

Posted on Jun 6th, 2018

Enzymatic conjugation of peptides and their analogues to other peptides or proteins is considered to be an exciting field in protein chemistry. Besides Sortase A, Butelase and Transglutaminase, the field offers attractive possibilities with respect to its broad spectrum and simplicity.…

Continue reading >

Peptides as invaluable tools in the search for innovative analgesics

Posted on May 9th, 2018

Pain is a quite frequent complaint after injuries and accompanying different pathologies, which remains poorly treated for a number of patients. Pain involves extremely complex/interrelated series of signaling and modulatory pathways of the nervous system. Within them, the contribution to pain…

Continue reading >

Thiol additive-free native chemical ligation

Posted on Mar 13th, 2018

Native chemical ligation (NCL) commonly facilitates a peptide thioester with an N-terminal β-thiol peptide to form a native amide bond. Though many peptide thioester preparation strategies have been developed, it generally requires a large excess of exogenous thiol additives. Here I will discuss…

Continue reading >

Epigallocatechin Gallate – Unravelling its Effect on Amyloid and Toxic Oligomers

Posted on Feb 10th, 2018

Many medical disorders are associated with amyloid formation, Alzheimer disease (AD) and Parkinson disease (PD) being perhaps the most well-known. All such diseases have in common the pathological aggregation of a normally soluble polypeptide chain into a series of oligomeric intermediates and…

Continue reading >

Comments are closed.